Terms: = Sarcomas AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Treatment
5436 results:
1. Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina.
Pellicanò GF; Squeri A; Ciappina G; Squeri R; Palmara VI; Parisi S; Campo I; Saitta C; Rossanese M; Di Trapani E; Mancuso S; Catalano N; Allegra A; Mancuso G; Murolo G; Bignucolo A; Restivo DA; Consolo P; Berretta M
Eur Rev Med Pharmacol Sci; 2024 Apr; 28(7):2929-2942. PubMed ID: 38639530
[TBL] [Abstract] [Full Text] [Related]
2. Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer.
Razmara AM; Farley LE; Harris RM; Judge SJ; Lammers M; Iranpur KR; Johnson EG; Dunai C; Murphy WJ; Brown CT; Rebhun RB; Kent MS; Canter RJ
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631708
[TBL] [Abstract] [Full Text] [Related]
3. Transient Receptor Potential Ankyrin 1 Ion Channel Is Expressed in Osteosarcoma and Its Activation Reduces Viability.
Hudhud L; Rozmer K; Kecskés A; Pohóczky K; Bencze N; Buzás K; Szőke É; Helyes Z
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612571
[TBL] [Abstract] [Full Text] [Related]
4. Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues.
Sun X; Chang J; Zhou C; Zhao P; Guo S; Tong J; Wang Y; Yang Y
J Vis Exp; 2024 Mar; (205):. PubMed ID: 38587398
[TBL] [Abstract] [Full Text] [Related]
5. The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.
Das J; Bera S; Ganguly N; Guha I; Ghosh Halder T; Bhuniya A; Nandi P; Chakravarti M; Dhar S; Sarkar A; Das T; Banerjee S; Ghose S; Bose A; Baral R
Front Immunol; 2024; 15():1325161. PubMed ID: 38585261
[TBL] [Abstract] [Full Text] [Related]
6. Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk.
Piening A; Ebert E; Gottlieb C; Khojandi N; Kuehm LM; Hoft SG; Pyles KD; McCommis KS; DiPaolo RJ; Ferris ST; Alspach E; Teague RM
Nat Commun; 2024 Apr; 15(1):2835. PubMed ID: 38565540
[TBL] [Abstract] [Full Text] [Related]
7. Targeting RCC1 to block the human soft-tissue sarcoma by disrupting nucleo-cytoplasmic trafficking of Skp2.
Zhuang M; Li F; Liang H; Su Y; Cheng L; Lin B; Zhou J; Deng R; Chen L; Lyu P; Lu Z
Cell Death Dis; 2024 Apr; 15(4):241. PubMed ID: 38561375
[TBL] [Abstract] [Full Text] [Related]
8. Current and future genomic applications for surgeons.
Alkhatib O; Miles T; Jones RP; Mair R; Palmer R; Winter H; McDermott FD
Ann R Coll Surg Engl; 2024 Apr; 106(4):321-328. PubMed ID: 38555869
[TBL] [Abstract] [Full Text] [Related]
9. Investigating the correlation between prominent viruses and hematological malignancies: a literature review.
Haghtalab A; Hejazi M; Goharnia N; Yekanlou A; Hazhir K; Barghi A; Bazzaz Z; Allahverdizadeh I; GhalibafSabbaghi A
Med Oncol; 2024 Mar; 41(5):102. PubMed ID: 38546893
[TBL] [Abstract] [Full Text] [Related]
10. FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the treatment of Patients With Sarcoma?
Cengel KA; Kim MM; Diffenderfer ES; Busch TM
Semin Radiat Oncol; 2024 Apr; 34(2):218-228. PubMed ID: 38508786
[TBL] [Abstract] [Full Text] [Related]
11. Polyphyllin I enhances tumor necrosis factor-related apoptosis-inducing ligand-induced inhibition of human osteosarcoma cell growth downregulating the Wnt/β-catenin pathway.
Junli C; Fulai Z; Xingyuan S; Xiaoping MA; Peng Z; Chujie Z; Binhao S; Wenchao GU; Yongjun W; Yanping Y
J Tradit Chin Med; 2024 Apr; 44(2):251-259. PubMed ID: 38504531
[TBL] [Abstract] [Full Text] [Related]
12. A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers.
Kenney RT; Cini JK; Dexter S; DaFonseca M; Bingham J; Kuan I; Chawla SP; Polasek TM; Lickliter J; Ryan PJ
Front Immunol; 2024; 15():1362775. PubMed ID: 38487528
[TBL] [Abstract] [Full Text] [Related]
13. Management of
Malhotra J; Nguyen D; Tan T; Semeniuk Iii GB
Clin Adv Hematol Oncol; 2024 Mar; 22(2):67-75. PubMed ID: 38446474
[TBL] [Abstract] [Full Text] [Related]
14. Promising Dual Anticancer and Antimetastatic Action by a Cu(II) Complex Derived from Acylhydrazone on Human Osteosarcoma Models.
Santa Maria de la Parra L; Romo AIB; Rodríguez-López J; Nascimento OR; Echeverría GA; Piro OE; León IE
Inorg Chem; 2024 Mar; 63(11):4925-4938. PubMed ID: 38442008
[TBL] [Abstract] [Full Text] [Related]
15. [Effect of Staphylococcal Nuclease and Tudor Domain Containing 1/SLC7A11 on the Occurrence and Development of Osteosarcoma by Inhibiting Ferroptosis].
Wang ST; Xu SJ; Gui P; Li XN; Sui YH; Li ZX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):11-18. PubMed ID: 38433625
[TBL] [Abstract] [Full Text] [Related]
16. Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts.
Morinaga S; Han Q; Kubota Y; Mizuta K; Kang BM; Sato M; Bouvet M; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Higuchi T; Tsuchiya H; Hoffman RM
Anticancer Res; 2024 Mar; 44(3):921-928. PubMed ID: 38423656
[TBL] [Abstract] [Full Text] [Related]
17. The Effect of Photodynamic Therapy Using 5-Aminolevulinic Acid in Bone and Soft Tissue Sarcoma Cells.
Adachi R; Nakamura T; Nakata K; Uchiyama T; Hagi T; Asanuma K; Sudo A
Anticancer Res; 2024 Mar; 44(3):963-969. PubMed ID: 38423650
[TBL] [Abstract] [Full Text] [Related]
18. Repurposing of Loperamide as a New Drug With Anticancer Activity for Human Osteosarcoma.
Roncuzzi L; Perut F; Baldini N
Anticancer Res; 2024 Mar; 44(3):1063-1070. PubMed ID: 38423641
[TBL] [Abstract] [Full Text] [Related]
19. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
[TBL] [Abstract] [Full Text] [Related]
20. Association of MDM2 Overexpression in Ameloblastomas with
Tosios KI; Kalogirou EM; Koutlas IG
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396916
[TBL] [Abstract] [Full Text] [Related]
[Next]
